These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1024 related articles for article (PubMed ID: 16458969)
1. Associations between elevated intraocular pressure and glaucoma, use of glaucoma medications, and 5-year incident cataract: the Blue Mountains Eye Study. Chandrasekaran S; Cumming RG; Rochtchina E; Mitchell P Ophthalmology; 2006 Mar; 113(3):417-24. PubMed ID: 16458969 [TBL] [Abstract][Full Text] [Related]
2. Retinal vessel caliber is associated with the 10-year incidence of glaucoma: the Blue Mountains Eye Study. Kawasaki R; Wang JJ; Rochtchina E; Lee AJ; Wong TY; Mitchell P Ophthalmology; 2013 Jan; 120(1):84-90. PubMed ID: 23062656 [TBL] [Abstract][Full Text] [Related]
3. Use of inhaled and oral corticosteroids and the long-term risk of cataract. Wang JJ; Rochtchina E; Tan AG; Cumming RG; Leeder SR; Mitchell P Ophthalmology; 2009 Apr; 116(4):652-7. PubMed ID: 19243828 [TBL] [Abstract][Full Text] [Related]
4. Open-angle glaucoma and systemic thyroid disease in an older population: The Blue Mountains Eye Study. Lee AJ; Rochtchina E; Wang JJ; Healey PR; Mitchell P Eye (Lond); 2004 Jun; 18(6):600-8. PubMed ID: 14716330 [TBL] [Abstract][Full Text] [Related]
5. Glaucoma in a rural population of southern India: the Aravind comprehensive eye survey. Ramakrishnan R; Nirmalan PK; Krishnadas R; Thulasiraj RD; Tielsch JM; Katz J; Friedman DS; Robin AL Ophthalmology; 2003 Aug; 110(8):1484-90. PubMed ID: 12917161 [TBL] [Abstract][Full Text] [Related]
6. Inhaled corticosteroids, family history, and risk of glaucoma. Mitchell P; Cumming RG; Mackey DA Ophthalmology; 1999 Dec; 106(12):2301-6. PubMed ID: 10599661 [TBL] [Abstract][Full Text] [Related]
7. Retinal vessel diameter and open-angle glaucoma: the Blue Mountains Eye Study. Mitchell P; Leung H; Wang JJ; Rochtchina E; Lee AJ; Wong TY; Klein R Ophthalmology; 2005 Feb; 112(2):245-50. PubMed ID: 15691558 [TBL] [Abstract][Full Text] [Related]
8. Refractive associations with cataract: the Blue Mountains Eye Study. Lim R; Mitchell P; Cumming RG Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):3021-6. PubMed ID: 10549667 [TBL] [Abstract][Full Text] [Related]
9. Is renal impairment a predictor of the incidence of cataract or cataract surgery? Findings from a population-based study. Huynh SC; Kifley A; Strippoli GF; Mitchell P Ophthalmology; 2005 Feb; 112(2):293-300. PubMed ID: 15691566 [TBL] [Abstract][Full Text] [Related]
10. Retinal vessel caliber and the long-term incidence of age-related cataract: the Blue Mountains Eye Study. Tan AG; Mitchell P; Burlutsky G; Rochtchina E; Kanthan G; Islam FM; Wang JJ Ophthalmology; 2008 Oct; 115(10):1693-8, 1698.e1. PubMed ID: 18538403 [TBL] [Abstract][Full Text] [Related]
11. Myopia and incident cataract and cataract surgery: the blue mountains eye study. Younan C; Mitchell P; Cumming RG; Rochtchina E; Wang JJ Invest Ophthalmol Vis Sci; 2002 Dec; 43(12):3625-32. PubMed ID: 12454028 [TBL] [Abstract][Full Text] [Related]
12. The relation of retinal microvascular characteristics to age-related eye disease: the Beaver Dam eye study. Klein R; Klein BE; Tomany SC; Wong TY Am J Ophthalmol; 2004 Mar; 137(3):435-44. PubMed ID: 15013865 [TBL] [Abstract][Full Text] [Related]
13. Open-angle glaucoma and cardiovascular mortality: the Blue Mountains Eye Study. Lee AJ; Wang JJ; Kifley A; Mitchell P Ophthalmology; 2006 Jul; 113(7):1069-76. PubMed ID: 16815396 [TBL] [Abstract][Full Text] [Related]
14. The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study. Iwase A; Suzuki Y; Araie M; Yamamoto T; Abe H; Shirato S; Kuwayama Y; Mishima HK; Shimizu H; Tomita G; Inoue Y; Kitazawa Y; Ophthalmology; 2004 Sep; 111(9):1641-8. PubMed ID: 15350316 [TBL] [Abstract][Full Text] [Related]
15. Statin use and the long-term risk of incident cataract: the Blue Mountains Eye Study. Tan JS; Mitchell P; Rochtchina E; Wang JJ Am J Ophthalmol; 2007 Apr; 143(4):687-9. PubMed ID: 17386279 [TBL] [Abstract][Full Text] [Related]
16. Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial. Bengtsson B; Leske MC; Hyman L; Heijl A; Ophthalmology; 2007 Feb; 114(2):205-9. PubMed ID: 17097736 [TBL] [Abstract][Full Text] [Related]
17. Cataract progression after prophylactic laser peripheral iridotomy: potential implications for the prevention of glaucoma blindness. Lim LS; Husain R; Gazzard G; Seah SK; Aung T Ophthalmology; 2005 Aug; 112(8):1355-9. PubMed ID: 16061092 [TBL] [Abstract][Full Text] [Related]
18. Incidence of glaucomatous visual field loss: a ten-year follow-up from the Rotterdam Study. Czudowska MA; Ramdas WD; Wolfs RC; Hofman A; De Jong PT; Vingerling JR; Jansonius NM Ophthalmology; 2010 Sep; 117(9):1705-12. PubMed ID: 20591487 [TBL] [Abstract][Full Text] [Related]
19. Pseudoexfoliation syndrome and the long-term incidence of cataract and cataract surgery: the blue mountains eye study. Kanthan GL; Mitchell P; Burlutsky G; Rochtchina E; Wang JJ Am J Ophthalmol; 2013 Jan; 155(1):83-88.e1. PubMed ID: 23036566 [TBL] [Abstract][Full Text] [Related]
20. Pterygium, pinguecula, and 5-year incidence of cataract. Pham TQ; Wang JJ; Rochtchina E; Mitchell P Am J Ophthalmol; 2005 Jun; 139(6):1126-8. PubMed ID: 15953456 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]